Pembrolizumab with platinum- and fluoropyrimidine-based chemotherapy for untreated advanced HER2-negative gastric or gastro-oesophageal junction adenocarcinoma

Final draft guidance: 1

Final draft guidance (PDF 201 KB)

Committee papers (PDF 1.95 MB)

Public committee slides (PDF 462 KB)

Register of interests (PDF 138 KB)

Draft guidance

Draft guidance (online commenting)

Committee papers - ACM1 (PDF 7.67 MB)

Public committee slides - ACM1 (PDF 871 KB)

Equality impact assessment (PDF Version) - Draft Guidance (PDF 148 KB)

Draft guidance (PDF version) (PDF 192 KB)

Final scope (PDF 225 KB)

Final stakeholder list (PDF 164 KB)

Draft scope and provisional stakeholder list comments table (post-referral) (PDF 193 KB)

Final appraisal document (PDF 128 KB)

Draft matrix post referral (PDF 163 KB)

Draft scope post referral (PDF 230 KB)